352 related articles for article (PubMed ID: 11227252)
1. Acute community-acquired pneumonia: current diagnosis and treatment.
Bryan CS
J S C Med Assoc; 2001 Jan; 97(1):19-26. PubMed ID: 11227252
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of community-acquired pneumonia in adults.
Watkins RR; Lemonovich TL
Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
[TBL] [Abstract][Full Text] [Related]
3. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic and treatment of community-acquired pneumonia in the adult. Recommendations for clinical practice. By the "Practice guidelines for community-acquired pneumonia" Work Group].
Rev Med Suisse Romande; 1999 May; 119(5):403-27. PubMed ID: 10384776
[No Abstract] [Full Text] [Related]
5. Community-acquired pneumonia in adults: initial antibiotic therapy.
King DE; Pippin HJ
Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial treatment of lower respiratory tract infections in the hospital setting.
Grossman RF; Rotschafer JC; Tan JS
Am J Med; 2005 Jul; 118 Suppl 7A():29S-38S. PubMed ID: 15993675
[TBL] [Abstract][Full Text] [Related]
7. Atypical pathogens and challenges in community-acquired pneumonia.
Thibodeau KP; Viera AJ
Am Fam Physician; 2004 Apr; 69(7):1699-706. PubMed ID: 15086042
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
Querol-Ribelles JM; Tenías JM; Querol-Borrás JM; Labrador T; Nieto A; González-Granda D; Martínez I
Int J Antimicrob Agents; 2005 Jan; 25(1):75-83. PubMed ID: 15620830
[TBL] [Abstract][Full Text] [Related]
9. Institution-specific patterns of infection and Gram's stain as guides for empiric treatment of patients hospitalized with typical community-acquired pneumonia.
Belliveau P; Hickingbotham N; Maderazo EG; Mazens-Sullivan M; Robinson A
Pharmacotherapy; 1993; 13(4):396-401. PubMed ID: 8361868
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization.
Rosón B; Carratalà J; Verdaguer R; Dorca J; Manresa F; Gudiol F
Clin Infect Dis; 2000 Oct; 31(4):869-74. PubMed ID: 11049763
[TBL] [Abstract][Full Text] [Related]
11. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
12. [Community-acquired pneumonia in children: applications of the WHO decision trees in Switzerland].
Dirlewanger M; Krähenbühl JD; Fanconi S; Vaudaux B; Gehri M
Rev Med Suisse Romande; 2002 Dec; 122(12):595-8. PubMed ID: 12611183
[No Abstract] [Full Text] [Related]
13. Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia.
Wu JH; Howard DH; McGowan JE; Frau LM; Dai WS
Clin Ther; 2004 Dec; 26(12):2153-62. PubMed ID: 15823779
[TBL] [Abstract][Full Text] [Related]
14. The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques.
Manali E; Papadopoulos A; Tsiodras S; Polychronopoulos V; Giamarellou H; Kanellakopoulou K
Scand J Infect Dis; 2008; 40(4):286-92. PubMed ID: 17918018
[TBL] [Abstract][Full Text] [Related]
15. Lower respiratory tract infections and community acquired pneumonia in adults.
Stocks N; Turnidge J; Crockett A
Aust Fam Physician; 2004 May; 33(5):297-301. PubMed ID: 15227857
[TBL] [Abstract][Full Text] [Related]
16. [Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].
Benito JR; Montejo JM; Cancelo L; Zalacaín R; López L; Fernández Gil de Pareja J; Alonso E; Oñate J
Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):394-400. PubMed ID: 14525703
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
18. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
19. Empirical therapy of community-acquired pneumonia.
Niederman MS
Semin Respir Infect; 1994 Sep; 9(3):192-8. PubMed ID: 7831541
[TBL] [Abstract][Full Text] [Related]
20. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
